NCT01897571 2024-03-26Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLIpsenPhase 1/2 Completed400 enrolled 22 charts 3 FDA
NCT00003270 2019-12-13Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerRoswell Park Cancer InstitutePhase 2 Completed20 enrolled 11 charts
NCT01093586 2019-01-23Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 2 Completed14 enrolled 22 charts
NCT00482053 2018-05-14Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCTStanford UniversityPhase 2 Terminated3 enrolled 13 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts
NCT00109928 2014-10-01S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's LymphomaSWOG Cancer Research NetworkPhase 2 Completed34 enrolled 9 charts
NCT00057811 2014-09-19Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaChildren's Oncology GroupPhase 2 Completed97 enrolled 13 charts
NCT00608517 2014-05-20Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilVanderbilt-Ingram Cancer CenterPhase NA Terminated6 enrolled 13 charts